Single‐dose oral challenges to validate eliciting doses in children with cow’s milk allergy
Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (...
Saved in:
Published in | Pediatric allergy and immunology Vol. 32; no. 5; pp. 1056 - 1065 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.07.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0905-6157 1399-3038 1399-3038 |
DOI | 10.1111/pai.13482 |
Cover
Summary: | Background
There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.
Methods
Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.
Results
172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein.
Conclusions
These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed. |
---|---|
Bibliography: | Funding information Clinical challenges in the SOCMA study were funded through grant funds awarded by Jon Moulton Charity Trust, UK Medical Research Council (ref MR/S036954/1), Sociedad Española de Alergología e Inmunología Clínica (SEAIC), Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica (SEICAP) and Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0026). iFAAM (Integrated Approaches to Food Allergen and Allergy Risk Management) challenges were funded through the European Union's Seventh Framework Program for research, technological development and demonstration (grant agreement no. 312147). Additional funding for the Irish centre was obtained via a research fellowship (YD) from the National Children's Research Centre of Ireland, and for Hospital Clinico San Carlos in Madrid by Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0009). PJT is supported through the NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR, or the Department of Health. The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0905-6157 1399-3038 1399-3038 |
DOI: | 10.1111/pai.13482 |